Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses. - Wikidata - wikimedia - TriplyDB

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

http://www.wikidata.org/entity/Q33999615

about

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons Vaccination against canine parvoviral enteritis in healthy dogs.

P2860

Q36241275-D0DA46EF-B593-410C-9289-A179EB057FB7 Q54703466-F14BE164-EBF1-4221-AC49-07DA7657FA9B

P2860

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

http://www.wikidata.org/entity/Q33999615

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@ast

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@en

type

label

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@ast

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@en

prefLabel

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@ast

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@en

P1433

Q33999615-F56653CA-D359-4127-BF75-B76575B47F1E

P1476

Q33999615-2051B340-D986-431F-B00D-F930BFE2DD18

P2093

Q33999615-26FF39A8-A621-4416-B43B-452374631A46

Q33999615-393D5FF2-D792-40BF-8BDC-9668A0318FF2

Q33999615-42CEF00B-6B0A-4D64-936D-E7182EB4C39F

Q33999615-7D083CE3-C6B1-41F9-AEB3-0A22E43B8F2C

Q33999615-82BCA7DA-DA00-452D-9B73-AD982282B626

Q33999615-A5060526-C5C9-42E9-9C78-E859DDDD9124

Q33999615-B71AB52D-643F-4B54-9CD2-14CBDA7FEB29

P2860

Q33999615-0A1E7521-6427-41F1-A190-FD68BCB8E0F8

Q33999615-15FC44A1-117C-42BA-AF12-4BE61F8FEEF1

Q33999615-1771A29C-46DB-4B77-A666-9BA437DD3802

Q33999615-17BBED78-B89A-4823-A9AA-C85E33506B14

Q33999615-245E2A55-5D50-41A4-AF61-2167DAF92E95

Q33999615-2861538E-8073-43C2-ABD7-D20BF9895611

Q33999615-2A367F57-EDE7-4DBD-9808-49A98A67EFD6

Q33999615-31708D8B-C2FB-4CAB-B22D-36C3431F39B8

Q33999615-3F290257-949B-44BF-810B-A403F2AA1C45

Q33999615-4FAAEB4A-8422-48F2-84CE-6A6EA3AD38F8

P304

Q33999615-B04A4B97-4FF2-4388-9487-773027696C68

P31

Q33999615-2B9E3B85-20AE-4B55-A50B-F9AEAF5A4661

P356

Q33999615-05872184-46DF-4CD5-AF99-23722D46CAFE

P407

Q33999615-836AF3F5-9149-4705-99C8-EBE7FE42353A

P433

Q33999615-A27BBE54-4138-4A76-BF2E-2CBCAE9026D3

P478

Q33999615-C0FBF3CE-746F-4311-B651-0F29389CC8AF

P50

Q33999615-98EC6B3A-B0AB-4429-890B-58F1E5B7638B

Q33999615-ABD87D96-D399-4C73-9380-EA89BA0C2DC1

Q33999615-E0A31F3D-9AA2-4782-9728-60445DC595F9

P577

Q33999615-D9F43BB6-44CF-4BAE-AF26-F3ABC4302975

P5875

Q33999615-CB0B9775-4B78-423C-9B0D-B9483135243E

P698

Q33999615-0994D543-51D4-41A3-A759-F03B3A4355FC

P932

Q33999615-04C87FE1-3D10-48DA-845A-FD32080749FF

P356

JOURNAL.PONE.0103446

P1433

P1476

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.

@en

P2093

Fatima Laher

http://www.w3.org/2001/XMLSchema#string

Gavin Churchyard

http://www.w3.org/2001/XMLSchema#string

Kathryn L Hopkins

http://www.w3.org/2001/XMLSchema#string

Kennedy Otwombe

http://www.w3.org/2001/XMLSchema#string

Koleka Mlisana

http://www.w3.org/2001/XMLSchema#string

Maphoshane Nchabeleng

http://www.w3.org/2001/XMLSchema#string

Stephen DeRosa

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Use of adenovirus in vaccines for HIV.

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

The potential role of biomarkers in HIV preventive vaccine trials

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Novel adenovirus vector-based vaccines for HIV-1.

Dose-dependent effects of alcohol on appetite and food intake.

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis.

P304

e103446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0103446

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

P577

2014-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264462094

http://www.w3.org/2001/XMLSchema#string

P698

25090110

http://www.w3.org/2001/XMLSchema#string

P932

4121165

http://www.w3.org/2001/XMLSchema#string